Can Anti-inflammatory Therapy Prevent Atrial Fibrillation in Myocardial Infarction Patients?

Int Heart J. 2018;59(1):3-5. doi: 10.1536/ihj.17-662.

Authors

Yukiteru Nakayama¹, Katsuhito Fujiu^{1

2}

Affiliations

¹ Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo.
² Department of Ubiquitous Health Informatics, School of Medicine, The University of Tokyo.

PMID: 29375115
DOI: 10.1536/ihj.17-662

No abstract available

Keywords: Arrythmia; Biomarker; Inflammation.

MeSH terms

Aged
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Anti-Inflammatory Agents / therapeutic use*
Atorvastatin / therapeutic use*
Atrial Fibrillation / drug therapy*
Atrial Fibrillation / etiology
Atrial Fibrillation / mortality
Atrial Fibrillation / prevention & control
Coronary Angiography / methods
Electrocardiography / methods
Female
Humans
Male
Middle Aged
Myocardial Infarction / complications
Myocardial Infarction / diagnostic imaging
Myocardial Infarction / drug therapy*
Myocardial Infarction / mortality
Myocardial Reperfusion / methods
Prognosis
Risk Assessment
Survival Rate
Treatment Outcome

Substances

Angiotensin-Converting Enzyme Inhibitors
Anti-Inflammatory Agents
Atorvastatin